Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat

Catechol-O-methyltransferase (COMT) has an important role in the extraneuronal inactivation of catecholamine neurotransmitters and drugs with a catechol structure. Two novel COMT inhibitors, OR-462 and OR-486, were highly effective (IC50 = 18 and 12 nM, respectively) and selective in inhibiting COMT...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	European journal of pharmacology Ročník 153; číslo 2-3; s. 263
Hlavní autoři:	Nissinen, E, Lindén, I B, Schultz, E, Kaakkola, S, Männistö, P T, Pohto, P
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Netherlands 24.08.1988
Témata:	Animals Brain - enzymology Carbidopa - administration & dosage Carbidopa - pharmacology Catechol O-Methyltransferase Inhibitors Catechols - administration & dosage Catechols - pharmacology Drug Interactions Duodenum - enzymology Erythrocytes - enzymology In Vitro Techniques Ketones - pharmacology Levodopa - administration & dosage Levodopa - blood Levodopa - pharmacology Liver - enzymology Male Pentanones - administration & dosage Pentanones - pharmacology Rats Rats, Inbred Strains Tyrosine - analogs & derivatives Tyrosine - blood
ISSN:	0014-2999
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Popis
Shrnutí:	Catechol-O-methyltransferase (COMT) has an important role in the extraneuronal inactivation of catecholamine neurotransmitters and drugs with a catechol structure. Two novel COMT inhibitors, OR-462 and OR-486, were highly effective (IC50 = 18 and 12 nM, respectively) and selective in inhibiting COMT activity in vitro. Tyrosine hydroxylase was not inhibited until micromolar concentrations of these compounds were used: the IC50 values for OR-462 and OR-486 were 10 and 14 microM, respectively. The IC50 values for dopamine-beta-hydroxylase, dopa-decarboxylase and monoamine oxidase forms A and B were greater than 50 microM. In studies ex vivo oral OR-462 inhibited mainly the COMT activity in the duodenum while OR-486 inhibited COMT activity in the liver and red blood cells as well. Oral OR-462 did not penetrate into the brain in doses up to 30 mg/kg while the same dose of OR-486 had some effect on striatal COMT activity. When tested in combination with levodopa-carbidopa, orally administered OR-462 and OR-486 were more effective in reducing the formation of 3-O-methyldopa from levodopa than was the levodopa-carbidopa treatment alone. These results indicate that OR-462 and OR-486 are effective and long-lasting inhibitors of COMT activity.
Bibliografie:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0014-2999
DOI:	10.1016/0014-2999(88)90614-0